Home / Nervous system / Risperidone
ATC N05AX08 · Psycholeptics
Risperidone shortage
As of 31 Oct 2026, Risperidone has a reported shortage in 5 of the 5 countries we track (Germany, Italy, Spain, Austria, Belgium), covering 45 products.
Countries5/5
Products45packs or presentations
Short since19 Feb 20242.7 years ago
Earliest return6 Nov 2026company estimate
No return date15products
Main reasonManufacturing problem
Timeline
GermanyItalySpainAustriaBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Risperidon-ratiopharm 25 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension | ratiopharm GmbH | 5 Sep 2024 | 30 Jun 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Risperidon-ratiopharm 25 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension | ratiopharm GmbH | 5 Sep 2024 | 30 Jun 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Risperidon-ratiopharm 37,5 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension | ratiopharm GmbH | 5 Sep 2024 | 30 Jun 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Risperidon-ratiopharm 37,5 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension | ratiopharm GmbH | 5 Sep 2024 | 30 Jun 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Risperidon-ratiopharm 50 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension | ratiopharm GmbH | 5 Sep 2024 | 30 Jun 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Risperidon-ratiopharm 50 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension | ratiopharm GmbH | 5 Sep 2024 | 30 Jun 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Risperidon - 1 A Pharma 6 mg Filmtabletten | 1 A Pharma GmbH | 29 May 2026 | 12 Jan 2027 | Increased demand Erhöhte Nachfrage |
| DE | Risperidon - 1 A Pharma 6 mg Filmtabletten | 1 A Pharma GmbH | 29 May 2026 | 12 Jan 2027 | Increased demand Erhöhte Nachfrage |
| DE | Risperidon Mylan 1 mg Filmtabletten | Viatris Germany GmbH | 2 Jun 2026 | 15 Apr 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Risperidon Mylan 2 mg Filmtabletten | Viatris Germany GmbH | 2 Jun 2026 | 15 Apr 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Risperidon Mylan 3 mg Filmtabletten | Viatris Germany GmbH | 2 Jun 2026 | 15 Apr 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Risperidon Mylan 4 mg Filmtabletten | Viatris Germany GmbH | 2 Jun 2026 | 15 Apr 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Risperidon AL 6 mg Filmtabletten | ALIUD PHARMA GmbH | 18 Jun 2026 | 26 Nov 2026 | Increased demand Erhöhte Nachfrage |
| IT | RISPERIDONE TEVA GROUP | TEVA ITALIA S.R.L. | 9 Dec 2024 | not given | Manufacturing problem Problemi produttivi |
| IT | RISPERIDONE TEVA GROUP | TEVA ITALIA S.R.L. | 7 Jul 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | RISPERIDONE TEVA GROUP | TEVA ITALIA S.R.L. | 19 Sep 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | RISPERIDONE MYLAN PHARMA | MYLAN S.P.A. | 1 Sep 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | RISPERIDONE MYLAN PHARMA | MYLAN S.P.A. | 5 Sep 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | RISPERIDONE MYLAN PHARMA | MYLAN S.P.A. | 7 Oct 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | RISPERIDONE MYLAN PHARMA announced | MYLAN S.P.A. | 1 Dec 2026 | not given | Manufacturing problem Problemi produttivi |
| ES | RISPERIDONA TEVA 50 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG, 1 vial + 1 jeringa pregargada de disolvente + 1 adaptador vial + 2 agujas | Teva Gmbh | 8 Aug 2024 | 30 Dec 2027 | Not stated |
| ES | RISPERIDONA TEVA 25 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG, 1 vial + 1 jeringa pregargada de disolvente + 1 adaptador vial + 2 agujas | Teva Gmbh | 26 Aug 2024 | 30 Dec 2027 | Not stated |
| ES | RISPERIDONA TEVA 37,5 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFG, 1 vial + 1 jeringa pregargada de disolvente + 1 adaptador vial + 2 agujas | Teva Gmbh | 8 Sep 2024 | 30 Dec 2027 | Not stated |
| ES | RISPERIDONA VIATRIS 0,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | Viatris Limited | 18 Jul 2025 | 6 May 2027 | Not stated |
| ES | RISPERIDONA SANDOZ 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 60 comprimidos | Sandoz Farmaceutica S.A. | 22 Mar 2026 | not given | Not stated |
| ES | RISPERIDONA SANDOZ 3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 60 comprimidos | Sandoz Farmaceutica S.A. | 22 Mar 2026 | not given | Not stated |
| ES | RISPERIDONA VIATRIS 6 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | Viatris Limited | 16 Apr 2026 | 6 May 2027 | Not stated |
| ES | RISPERIDONA VIATRIS 3 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos | Viatris Limited | 24 May 2026 | 6 May 2027 | Not stated |
| ES | RISPERIDONA VIATRIS 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos | Viatris Limited | 27 May 2026 | 6 May 2027 | Not stated |
| ES | RISPERIDONA VIATRIS 0,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | Viatris Limited | 10 Jun 2026 | 23 Mar 2027 | Not stated |
| ES | RISPERIDONA VIATRIS 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos | Viatris Limited | 23 Jul 2026 | 6 May 2027 | Not stated |
| ES | RISPERIDONA VIATRIS 4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | Viatris Limited | 23 Jul 2026 | 6 May 2027 | Not stated |
| ES | RISPERIDONA VIATRIS 1 MG/ML SOLUCION ORAL EFG, 1 frasco de 100 ml | Viatris Limited | 29 Jul 2026 | 6 Dec 2026 | Not stated |
| AT | Risperidon ratiopharm 37,5 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension, 1 Stück | ratiopharm Arzneimittel Vertriebs GmbH | 6 May 2025 | not given | Manufacturing problem Verzögerung bei der Herstellung |
| AT | Risperidon ratiopharm 25 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension, 1 Stück | ratiopharm Arzneimittel Vertriebs GmbH | 26 May 2025 | not given | Manufacturing problem Verzögerung bei der Herstellung |
| AT | Risperidon ratiopharm 50 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension, 1 Stück | ratiopharm Arzneimittel Vertriebs GmbH | 12 Jun 2025 | not given | Distribution or logistics Verzögerung bei der Auslieferung |
| AT | Risperidon Actavis 50 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension, 1 Stück | Actavis Group PTC ehf. | 16 Jun 2025 | not given | Manufacturing problem Verzögerung bei der Herstellung |
| AT | Risperidon Actavis 25 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension, 1 Stück | Actavis Group PTC ehf. | 2 Jul 2025 | not given | Manufacturing problem Verzögerung bei der Herstellung |
| AT | Risperidon Actavis 37,5 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension, 1 Stück | Actavis Group PTC ehf. | 2 Jul 2025 | not given | Manufacturing problem Verzögerung bei der Herstellung |
| BE | Risperidone EG 6 mg film-coat. tabl. 100 (5 x 20) | EG | 19 Feb 2024 | 6 Nov 2026 | Manufacturing problem Delay in production |
| BE | Risperidone Teva 25 mg inj. susp. prol.-rel. (pwdr. + solv.) i.m. vial + pre-filled syr. 25 mg + 2 ml | Teva | 3 Oct 2025 | 5 May 2027 | Manufacturing problem Delay in production |
| BE | Risperidone Teva 37.5 mg inj. susp. prol.-rel. (pwdr. + solv.) i.m. vial + pre-filled syr. 37.5 mg + 2 ml | Teva | 5 Dec 2025 | 5 May 2027 | Manufacturing problem Delay in production |
| BE | Risperidone Teva 50 mg inj. susp. prol.-rel. (pwdr. + solv.) i.m. vial + pre-filled syr. 50 mg + 2 ml | Teva | 30 Mar 2026 | 10 May 2027 | Manufacturing problem Delay in production |
| BE | Risperidone EG 2 mg film-coat. tabl. 20 | EG | 30 Apr 2026 | 9 Nov 2026 | Other Other reason |
| BE | Risperdal 1 mg/ml or. sol. 100 ml | Janssen-Cilag | 27 Oct 2026 | 17 Nov 2026 | Manufacturing problem Delay in production |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.